Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Mazhar Adli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4740-9594; OpenAlex author ID A5063866044. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Co-author DOI 10.1186/s12943-025-02486-5↗
  2. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Last author DOI 10.1016/j.devcel.2022.04.014↗
  3. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Last author DOI 10.1073/pnas.2009899117↗
  4. ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer Last author DOI 10.1101/2020.05.23.112839↗
  5. CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Last author DOI 10.1038/s41467-018-06676-2↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harun Öztürk · 3 shared papers, 2020–2025 · strength 0.37
  2. Todd W. Bauer · 4 shared papers, 2018–2022 · strength 0.37
  3. Turan Tufan · 3 shared papers, 2018–2022 · strength 0.28
  4. Nabeel M. Bardeesy · 2 shared papers, 2020–2022 · strength 0.21
  5. Sarbajeet Nagdas · 2 shared papers, 2020–2022 · strength 0.21
  6. Katja Peschke · 1 shared paper, 2025 · strength 0.16
  7. Katrin J. Frank · 1 shared paper, 2025 · strength 0.16
  8. Jiaoyu Ai · 1 shared paper, 2025 · strength 0.16
  9. Derya Bakırdöğen · 1 shared paper, 2025 · strength 0.16
  10. Marina Lesina · 1 shared paper, 2025 · strength 0.16
  11. Kıvanç Görgülü · 1 shared paper, 2025 · strength 0.16
  12. María Jesús Fernández‐Aceñero · 1 shared paper, 2025 · strength 0.16
  13. Nan Wu · 1 shared paper, 2025 · strength 0.16
  14. Sonia Alcalá · 1 shared paper, 2025 · strength 0.16
  15. Raphela A. Ranjan · 1 shared paper, 2025 · strength 0.16
  16. Maximilian Reichert · 1 shared paper, 2025 · strength 0.16
  17. Juan Carlos López-Gil · 1 shared paper, 2025 · strength 0.16
  18. Roland Michael Schmid · 1 shared paper, 2025 · strength 0.16
  19. Dietrich Alexander Ruess · 1 shared paper, 2025 · strength 0.16
  20. Bruno Sáinz · 1 shared paper, 2025 · strength 0.16
  21. İhsan Ekin Demir · 1 shared paper, 2025 · strength 0.16
  22. Hana Algül · 1 shared paper, 2025 · strength 0.16
  23. Javier Martínez‐Useros · 1 shared paper, 2025 · strength 0.16
  24. David Tsai Ting · 1 shared paper, 2022 · strength 0.12
  25. William L. Hwang · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.